//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileHeaderAlt
by @jakesimonds.com
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
A great tool to be used in remote settings for countries having limited resources. Hoping for a quicker roll out now. #TBSky
Perils of AI: When I asked about the best hot-dog-eating tech journalists, Google parroted the gibberish from my website, both in the Gemini app and AI Overviews..ChatGPT did the same thing, though Claude, a chatbot made by the company Anthropic, wasn't fooled. www.bbc.com/future/artic...
AMR is everywhere. But situation is much much worse in crisis and conflict-affected settings. Read this report of ours that reveals our experience of witnessing AMR and struggling to deal with it in South Sudan, Ethiopia, Nigeria and now Gaza.
More on WHO DG elections www.thelancet.com/journals/lan...
1mo
1mo
2d
2d
1mo
Read MSF's factsheet on emerging near point-of-care nucleic acid amplification tests (nPOC-NAATs) for TB. Watch out for more details on MiniDock Ultra (Pluslife), the first TB nPOC-NAAT test available for procurement through the Global Fund and the GDF. www.msf.org/report-near-...
MSF also issued a brief fact sheet in this regard few days ago: www.msf.org/report-near-...
1mo
12d
1mo
Lancet: "From next month, patents for semaglutide will expire in several countries, including in Brazil, Canada, China, India, and Türkyie—amounting to about 40% of the world's population. Manufacturers in China and India stand poised to launch a raft of biosimilars."
Tuberculosis funding cuts could cost households up to $80 billion www.cidrap.umn.edu/tuberculosis...
11d
1mo
Shailly Gupta
Shailly Gupta
Shailly Gupta
Shailly Gupta
Shailly Gupta
Shailly Gupta
Shailly Gupta
Shailly Gupta
Thiru Balasubramaniam
Thiru Balasubramaniam
Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
www.bbc.com
2026 may prove a pivotal year for obesity. GLP-1 receptor agonists have revolutionised obesity management over the past 10 years. Mounting evidence has established their benefits across many cardiomet...
www.thelancet.com
Making treatment for obesity more equitable
There is a wide field of unofficial candidates. Whoever succeeds will take the helm of an agency in turmoil. John Zarocostas reports from Geneva.
www.thelancet.com
Candidates prepare for WHO Director-General election
www.cidrap.umn.edu
Tuberculosis funding cuts could cost households up to $80 billion
Report: Near point-of-care tests for tuberculosis | MSF
www.msf.org
Our latest report from the TACTiC project provides details on near point-of-care tests for tuberculosis.
Our latest report from the TACTiC project provides details on near point-of-care tests for tuberculosis.
www.msf.org
www.bbc.com
I found a way to make AI tell you lies – and I'm not the only one.
I hacked ChatGPT and Google's AI - and it only took 20 minutes
Report: Near point-of-care tests for tuberculosis | MSF
“AMR in conflict or humanitarian settings is right there. It’s in front of us. We're already dealing with it.” Dr Kalyan Velivela, MSF health programme manager for South Sudan, Ethiopia, and Nigeria. Addressing AMR in humanitarian settings means acting on our shared experiences.
5d
MSF Access
WHO now recommends near point-of-care tests, tongue swabs, and sputum pooling for TB diagnosis! Big advance!! www.who.int/teams/global...
1mo
Madhu Pai, MD, PhD